Arif Bilal

CIK 00019597502 companiesFRAMINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001959750

Recent Transactions

46 trades

Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (Right to Buy)
2026-06-11−100,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-06-11−49,000→ 0 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2026-01-16+49,000→ 49,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (right to buy)
2025-10-08+100,000→ 100,000 total
Award
Sarepta Therapeutics, Inc.$SRPT
Performance Stock Units
2025-08-05+6,250→ 6,250 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock Options (right to buy)
2025-03-10+16,644→ 16,644 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2025-03-10$100.13/sh−523→ 24,224 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2025-03-10+8,276→ 32,500 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2025-03-07$103.70/sh−8,527→ 24,747 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2025-03-07$103.70/sh−508→ 33,274 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Performance Stock Units
2025-03-06−17,500→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2025-03-06+17,500→ 33,782 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2025-03-04$101.34/sh−233→ 16,282 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2025-03-04$101.34/sh−281→ 16,515 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2025-03-03$103.77/sh−719→ 16,796 total
Award
Sarepta Therapeutics, Inc.$SRPT
Performance Restricted Stock Units
2025-02-11+3,500→ 17,500 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-06-25$163.23/sh−3,898→ 17,363 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-06-24$163.83/sh−1,055→ 22,485 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-06-24$164.64/sh−2,352→ 29,120 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-06-24$166.10/sh−700→ 21,485 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-06-24$162.31/sh−5,580→ 23,540 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-06-24$167.13/sh−224→ 21,261 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-06-24$164.61/sh−300→ 22,185 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Performance Stock Units
2024-06-21−6,250→ 0 total
Award
Sarepta Therapeutics, Inc.$SRPT
Performance Stock Units
2024-06-21+6,250→ 6,250 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-06-21+6,250→ 31,472 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-08$123.14/sh−472→ 25,222 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-07$120.49/sh−506→ 25,694 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-04$125.32/sh−285→ 26,437 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-04$125.32/sh−237→ 26,200 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-01+6,000→ 28,836 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-01$126.19/sh−251→ 22,836 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-01$126.19/sh−114→ 26,722 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock Option (right to buy)
2024-03-01−12,500→ 12,500 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-01$129.71/sh−457→ 26,836 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2024-03-01$128.58/sh−1,543→ 27,293 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2023-12-01$80.34/sh−3,682→ 22,886 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2023-03-30$136.66/sh−307→ 26,367 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2023-03-08$153.19/sh−314→ 26,674 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock Option (right to buy)
2023-03-06+27,000→ 27,000 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2023-03-06$157.21/sh−186→ 22,642 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2023-03-06+4,500→ 26,988 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2023-03-06$157.21/sh−154→ 22,488 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2023-03-01$147.57/sh−80→ 22,837 total
Tax Payment
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2023-03-01$147.57/sh−172→ 22,828 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock Option (right to buy)
2022-12-31+30,000→ 30,000 total

Companies

Recent Filings

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov